VDP

Dược phẩm Trung ương VIDIPHA ·HOSE ·2026Q1

▼ Under pressure

Working capital is tied up too long in the operating cycle Working capital 190 days
Price
54,000
Latest close
03 Jun 2026
P/E 19.36x
P/B 1.56x
EPS 2,789
BVPS 34,505
ROE 8.1%
ROA 6.0%
Profit Margin 6.6%
Asset Turnover 0.91x
Equity Mult. 1.36x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, VDP is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — margins have been compressing consistently over multiple periods. What remains unclear is whether the business can stabilize before this trend deepens.

TTM REVENUE
VND 937bn
−2.1%YoY
NET MARGIN
6.58%
−0.6ppYoY
TTM NET PROFIT
VND 62bn
−10.4%YoY
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 195.9 156.8 358.6 225.1 210.3 307.7 213.5 225.5 201.5 289.4 213.9 245.8
Growth +25% -56% +59% +7% -32% +44% -5% +12% -30% +35% -13%
Net Income 11.9 19.5 12.0 18.2 14.1 23.4 15.6 15.6 17.6 20.9 11.6 27.6
Net Margin 6.08% 12.45% 3.34% 8.06% 6.72% 7.62% 7.29% 6.94% 8.71% 7.23% 5.40% 11.21%

Drivers of VDP's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to higher selling expenses. Supporting and offsetting drivers:

Gross profit ↑ 14.3bn
Finance costs ↓ 5.0bn
Selling expenses ↑ 16.1bn
Other profit ↓ 4.8bn
Financial income ↓ 4.3bn
Tax ↑ 1.2bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:

Other profit ↑ 2.5bn
Finance costs ↓ 1.0bn
Tax ↓ 0.6bn
Financial income ↑ 0.5bn
Gross profit ↓ 4.3bn
Selling expenses ↑ 2.0bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 9.2% = 7.2% × 0.89 × 1.44
2026Q1 8.1% = 6.6% × 0.91 × 1.36

ROE fell from 9.2% to 8.1% — leverage weakened the most, though asset turnover still provided support.

Net margin: 6.6% -0.6pp Asset turnover: 0.91x +0.02x Leverage: 1.36x -0.09x

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

very positive positive stable watch under pressure

What is driving the margin?

Net margin narrowed to 6.58%, falling 0.6pp. The main pressure is SG&A / Revenue rose 2.1pp, outweighing the improvement in Gross margin rose 2.1pp (in addition, Net financial result / Revenue rose 0.1pp added support while Other profit / Revenue fell 0.5pp remained a drag).

The pressure comes from non-core items while core operations hold their rhythm — margin has a basis to recover once this factor passes.

Profitability trend

Net Margin 6.58% −0.6pp
Gross Margin 26.95% +2.1pp
SG&A / Revenue 18.45% +2.1pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Evaluate capital, asset, and working-capital efficiency.

Is capital being deployed efficiently?

ROIC stands at 8.28%, broadly flat versus the same period. That translates to 8.28 in after-tax operating profit for every 100 units of operating capital. NOPAT margin narrowed 0.2pp, but capital turnover rose 0.08x, with invested capital easing slightly by 70bn — the two factors are offsetting each other, keeping overall ROIC nearly unchanged.

Overall ROIC is flat while internal components are moving — watch which side becomes dominant in coming periods.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 8.28% +0.3pp
NOPAT Margin 6.69% −0.2pp
Capital Turnover 1.24x +0.08x
Average Invested Capital 756.4bn −69.8bn

Balance Sheet

Balance sheet is exceptionally sound — liabilities at 0.49x equity, with a net cash position equivalent to 0.09x equity.

Inventory ended the period at 283.6bn, roughly 25.4% of total assets.

Over the last 12 months, working capital released 163.3bn of cash, mainly thanks to lower receivables and lower inventories. Pressure from lower payables only partly offset that benefit.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables decreased → higher CFO: +82.1bn
Inventories decreased → higher CFO: +92.7bn
Payables decreased → lower CFO: −11.4bn

Working Capital Efficiency

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 9.1 days versus the same period last year. The main moves came from DIO fell 12.9 days, DSO fell 1.9 days, and DPO fell 5.6 days.

Improvement comes mainly from faster inventory turnover — watch whether this trend persists in coming periods.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 189.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 63.9 days −1.9 days
Inventory 160.1 days −12.9 days
Payables 34.1 days −5.6 days
Cash Conversion Cycle 189.9 days −9.1 days

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 238.2bn.

Leverage & Liquidity

Leverage looks fairly comfortable, with net debt / equity at -0.09x and interest coverage at 6.57x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 139.7% of debt, and total debt stands at 171.1bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Leverage and liquidity trend

Net Debt / Equity -0.09x −0.17x
Interest Coverage 6.57x +1.81x
Cash / Debt 139.7% +79.0pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI 4.16x +4.57x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 238.2bn in 2025, against investing cash flow of -66.2bn.

Post-investment cash flow was positive +172.1bn. Financing cash flow was negative +115.0bn.

CFO / net income was 4.16x.

After spending +19.6bn on fixed-asset investment, the business generated trailing free cash flow of +236.5bn.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 256.2bn +284.7bn
Cash Capex 19.6bn −6.0bn
FCF TTM +236.5bn +290.7bn

Investment Takeaway

The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 190 days.

Improvement: earnings conversion looks more confirmed, with CFO / net income at 4.16x.

Key risk: working capital remains tied up for too long, with cash cycle at 189.9 days.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
985.6 934.5 1,019.3 1,007.8 775.5
Cost of Goods Sold
728.6 704.7 748.7 755.4 0.0
Gross Profit
257.1 229.7 270.6 252.4 178.4
Financial Expenses
13.5 17.9 27.6 24.5 -14.4
Selling Expenses
95.2 81.5 120.3 90.1 -72.8
General and Administrative Expenses
79.1 66.4 51.1 71.6 -59.5
Operating Profit
83.7 84.2 91.2 92.2 63.2
Profit Before Tax
83.5 90.4 100.6 93.3 70.4
Net Income
63.8 71.8 80.2 73.5 55.4
Profit Attributable to Parent
63.8 71.8 80.2 73.5 55.4
Earnings per Share
2,889.00 3,252.00 4,766.00 4,029.00 3,444.39

Explore Other Stocks In The Same Sector

DHG, DVN, IMP, DBD, DTP, TRA, DMC, DP3, OPC, NDC, DAN, PMC, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.